AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Short-Acting Beta Agonists (SABA)
Description: Pharmaceutical form:Varies and depends on pharmaceutical presentation-Route of administration:Oral Inhalation
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form:Solution for injection in vial-Route of administration:Subcutaneous injection
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol
Description: Pharmaceutical form:Varies and depends on pharmaceutical presentation-Route of administration:Oral Inhalation
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluticasone/salmeterol
Description: Pharmaceutical form:Varies and depends on pharmaceutical presentation-Route of administration:Oral Inhalation
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol
Description: Pharmaceutical form:Varies and depends on pharmaceutical presentation-Route of administration:Oral Inhalation
Study NCT06676319 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Budesonide/formoterol
Description: Pharmaceutical form:Varies and depends on pharmaceutical presentation-Route of administration:Oral Inhalation
Study NCT06204926 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AI diagnostic algorithm
Description: The SMILE procedures collected would be assessed by the algorithm. The performance of the algorithm would be assessed, including accuracy, AUC, sensitivity and specificity.
Study NCT06619093 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: 3 additional citrate tubes (2.7mL)
Study NCT06670729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quran listening
Description: listening to quran recitation via head phone
Study NCT06670729 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: silent headphones group
Description: headphones were silent, patient do not listen to any thing
Study NCT05496140 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CLS-R-FUERTE
Description: The CLS-R-FUERTE program is a remote school clinician training and comprehensive psychosocial intervention designed to improve attention and behavior in Mexican school-aged youth (grades 1-5). It contains the same evidence-based service components to improve youth attention/behavior as the in-person CLS-FUERTE program; specifically, it features school clinician training by a clinical research team to lead parent skill groups, child skill groups, and teacher consultation in a behavioral classroom management system.
Study NCT06619860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-993
Description: Tablets for oral administration.
Study NCT06619860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin
Description: Capsules for oral administration.
Study NCT06619860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (matched to pregabalin)
Description: Placebo matched to pregabalin for oral administration.
Study NCT06619860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (matched to VX-993)
Description: Placebo matched to VX-993 for oral administration.
Study NCT06186414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237
Description: Several dose levels of SIM0237 will be administered as a single agent for evaluation
Study NCT06186414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237 and BCG
Description: Several dose levels of SIM0237 will be administered in combination with a fixed dose of BCG for evaluation
Study NCT06186414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237
Description: RD level of SIM0237 will be administered as a single agent for evaluation
Study NCT06186414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237 and BCG
Description: RD level of SIM0237 will be administered in combination with a fixed dose of BCG for evaluation
Study NCT06067438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone Hydrochloride
Description: Given IV and via feeding tube
Study NCT06067438 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Given IV
Study NCT06627933 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05292170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heat acclimation
Description: 10 consecutive days of heat acclimation
Study NCT05092061 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate-repetition resistance training
Description: Will undertake resistance training with moderate loads, and moderate repetitions 3 times per week for 7 weeks.
Study NCT05092061 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-repetition resistance training
Description: Will undertake resistance training with low loads, and high repetitions 3 times per week for 7 weeks.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g glucose diluted in 300mL water, tested two times, in different visits, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control juice
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g available carbohydrates from control juice (consisted of pomegranate, grape, apple and orange), tested once, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Juice with vitamin D3
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g available carbohydrates from juice (consisted of pomegranate, grape, apple and orange) containing vitamin D3, tested once, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Juice with n-3 fatty acids
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g available carbohydrates from juice (consisted of pomegranate, grape, apple and orange) containing n-3 fatty acids, tested once, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Juice with probiotics
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g available carbohydrates from juice (consisted of pomegranate, grape, apple and orange) containing probiotics, tested once, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05702359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Juice with probiotics, vitamin D3, and n-3 fatty acids
Description: Eleven healthy, normal body weight subjects after 10-14hr fast, consumed 50g available carbohydrates from juice (consisted of pomegranate, grape, apple and orange) containing probiotics, vitamin D3 and n-3 fatty acids, tested once, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 min. Salivary insulin samples were taken at baseline, 15, 30, 45, 60, 90, 120, and 180 min.
Study NCT05153356 — intervention group
Intervention type: DEVICE
Intervention: Personal Kinetigraph, Kinesia 360
Description: 10 patients will be assigned to each technology with a crossover at 3 months for a total of 20 patients over 6 months, 6 timepoints with data collected every 2 weeks.
Study NCT06324253 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: bilateral Erector spine block,A dose of 30 ml 0.125% Bupivacaine will be injected.
Description: will receive bilateral Erector Spinae Block after induction of anesthesia
Study NCT06324253 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic epidural analgesia
Description: will receive Thoracic Epidural Block before induction of anesthesia .a bolus dose of 10 ml of 0.125% bupivacaine through epidural catheter followed by continuous infusion of 0.125% bupivacaine at the rate of 0.1 ml/kg/hour
Study NCT06358352 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lutein / Zeaxanthin
Description: lutein extract from lutein oral capsules
Study NCT06358352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin
Description: platelet rich fibrin extracted from patient's blood after centrifuging
Study NCT06482593 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zinc-Oxide Eugenol Sealer
Description: Zinc oxide-eugenol sealers have a slow setting time, shrinkage while setting, solubility, and can discolour tooth structure. This sealer group has an advantage in terms of antibacterial activity.It will absorb if extruded into the periradicular tissues.
Study NCT06482593 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AH-Plus Epoxy Resin Sealer
Description: Dentsply AH Plus Root Canal Sealing Material is a two-component paste/paste root canal sealer based on epoxy-amine resin. The AH Plus sealer shows extremely low shrinkage making it a suitable choice of material to seal the root canal.
Study NCT06482593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bio-C Sealer
Description: Bio-C® Sealer is a ready-to-use, bioceramic root canal sealer with biologically active ingredients to seal and heal the root canal space. Bio-C Sealer's mechanical and physical properties make it easy to manipulate and seal the canals, while its biological properties and high pH ensure safety and treatment success.
Study NCT04832074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: Real Dry Needling in the most active Myofascial Trigger Point
Study NCT04832074 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Dry Needling
Description: Sham Dry Needling in the same location, but not piercing the skin
Study NCT05668871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danning Tablet
Description: 3 times each day, 5 tablets each time, take orally after meals.
Study NCT06200961 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transnasal Endoscopy
Description: Unsedated endoscopic evaluation through the nose.
Study NCT06694311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP
Description: 12 cmH2O for 48 hours (at least 10 hours of therapy per day). Nasobucal interface will be the preferred route with complete facial mask being also an acceptable device. If needed, therapy breaks will be delivered with HFNO at 50 L/min.~Non-invasive ventilation will not be allowed.~After 48 hours of treatment, clinicians will be able to decide the respiratory support to be provided although CPAP will be recommended to be continued as long as PaO2/FiO2 is less than or equal to 300 and inspired oxygen fraction is 40% or more.
Study NCT06694311 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HFNO 50 L/min
Description: HFNO 50 L/min for 48 hours. Therapy breaks with oxygen facemask will be allowed as per clinician decision but the protocol will advise against this practice.~Non-invasive ventilation will not be allowed.~After 48 hours of treatment, clinicians will be able to decide the respiratory support to be provided although HFNO will be recommended to be continued as long as PaO2/FiO2 is less than or equal to 300 and inspired oxygen fraction is 40% or more.
Study NCT06200961 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esophagogastroduodenoscopy
Description: Sedated endoscopic evaluation through the mouth.
Study NCT05890456 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Students with Involved Families and Teacher Program
Description: The SWIFT Program is a 9-12 month intervention that includes four components: (a) behavioral progress monitoring, (b) clinical supervision of the intervention elements and coordination with the school, (c) parent support to promote parent engagement/collaboration with the school and study routines in the home, and (d) behavioral skills coaching for students.
Study NCT05890456 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Services As Usual
Description: The SAU students and families will continue to receive any services that they were receiving prior to their entry into the study. These may include school-based interventions and supports and related services as required in the student's Individualized Education Program.
Study NCT06180096 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Riociguat film coated tablets
Description: 1 tablet of 2.5 mg Riociguat
Study NCT06180096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat film coated tablets
Description: 1 tablet of 2.5 mg Riociguat
Study NCT06180096 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adempas Filmtabletten
Description: 1 tablet of 2.5 mg Riociguat
Study NCT06180096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adempas Filmtabletten
Description: 1 tablet of 2.5 mg Riociguat
Study NCT06482398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sericin extract and turmeric extract cream
Description: Apply the sample 2 times a day for 8 weeks
Study NCT06482398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone acetonide 1% Cream
Description: Apply the sample 2 times a day for 8 weeks
Study NCT04735601 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ahmed Valve
Description: Ahmed valve implantation coated with poly lactic -co-glycolic acid (PLGA) saturated with Mitomycin-C in the management of adult onset glaucoma in Sturge Weber syndrome
Study NCT04735601 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ahmed Valve
Description: Ahmed valve implantation coated with poly lactic -co-glycolic acid (PLGA) saturated with Mitomycin-C in the management of adult onset glaucoma in Sturge Weber syndrome
Study NCT06150378 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid
Description: Patients that receive an injection with corticosteroid
Study NCT06150378 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plathet rich plasma
Description: Patients that receive an injection with Plathet-rich plasma
Study NCT06695546 — intervention group
Intervention type: OTHER
Intervention: VExUS evaluation ultrasound
Description: VExUS evaluation by ultrasound will be performed before the filling/bleeding/cleaning procedure, and again after the procedure:~* Inferior vena cava measurement in Time-Motion (TM) mode, 1-2 cm from the right atrial orifice.~* Hepatic venous Doppler measurement in pulsed Doppler mode.~* Renal vein Doppler measurement in pulsed Doppler mode. Each measurement is performed three times consecutively (to average the results), then the ultrasound measurements are compiled into a score according to the degree of doppler severity.
Study NCT05743283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SynEx Wound Cleanser
Description: SynEx is a concentrated form of SynePure®, an FDA 510(k) cleared aqueous, osmotically balanced wound cleanser containing patented chitosan derivatives. The ingredients are USP purified water, chitosan arginine (a patented chitosan derivative), sorbitol powder, and betaine. SynEx cleanser is packaged in a collapsible plastic pouch for reconstitution in water before debriding and cleansing a wound.
Study NCT05743283 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: The saline solution is composed of water and salt. It is packaged in a collapsible plastic pouch.
Study NCT06544486 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Caries Removal
Description: The cavity preparation and restoration were performed by a single operator. Infected dentin tissue was selectively removed. The differentiation between infected and affected dentin was determined by the clinician through the visual-tactile method.Isolation was achieved with cotton rolls and suction.
Study NCT06544486 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Filling
Description: Sectional matrix systems and interdental wedges were used to achieve an anatomical contour and contact. Then, the selected materials were placed in the cavity according to the manufacturers' recommendations.
Study NCT06536712 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells Derived Exosomes
Description: Mesenchymal Stem Cells Derived Exosomes will be administered intraperitoneally to patients at the end of their surgery
Study NCT06536712 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 10 patients will receive intraperitoneal placebo at the end of their surgery
Study NCT06263309 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Femoral neck shortening measurement
Description: We examine femoral neck shortening in patients with femoral neck fractures.
Study NCT05774509 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells
Description: Repeated (X3) intravenous infusions of the extracellular vesicle-enriched secretome of cardiovascular progenitor cells (differentiated from human induced pluripotent stem cells)
Study NCT05124756 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bioelectric stimulation
Description: The sessions will include 20 minutes for stimulation of the thigh muscles and 45 minutes for stimulation of the kidneys. The electrodes will be placed on the motor point of the quadriceps muscle in both lower limbs. The neuromuscular electric stimulation will be applied by symmetrical biphasic pulsed current, at an 80 Hz frequency, 400 ms pulse width, 10 s contraction time, rest time decreasing as the protocol advanced, at reciprocal mode. The intensity will be individually adjusted to produce visible muscle contraction. Concomitant, two electrodes will be placed in the abdominal corresponding to the kidney anatomical site and two electrodes on the dorsal region at the level of the 10th thoracic vertebra. The stimulation of the kidneys will include in addition to Klotho, precise signals for several pro-regenerative proteins. The intensity of the electric current will be individually adjusted to sensory stimulation.
Study NCT04813900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lung ultrasound
Description: Lung ultrasound in order to calculate lung ultrasound score
Study NCT06503341 — intervention group
Intervention type: OTHER
Intervention: Cardiovascular risk assesment
Description: ASCVD Score and WHO Cardiovascular Risk score.
Study NCT06479694 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Real-life Dual-Task Training
Description: The intervention is Real-life Dual-Task Training (Real-DTT) which uses instrumental activities of daily living training with explicit focus on the cognitive and motor elements and when to focus attention to one vs. the other to reduce fall risk. The Real-DTT sessions will be delivered once a week for 10 weeks during their occupational therapy sessions, delivered by a licensed occupational therapist. Real-DTT is a modified version of occupational therapy, with a protocol tailored to the participants.
Study NCT06701526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eptinezumab
Description: Solution for infusion
Study NCT05192226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counterfactual Strategy
Description: Participants in this intervention condition will think about their past and identify how a less than desirable physical activity event could have turned out better using counterfactual thinking (i.e., If only I... then....). After identifying actions they could have taken to reach a better outcome in their physical activity event, they will then apply those thoughts to the future upcoming week so they can be realized.
Study NCT04833842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-based childbirth preparation program developed based on health belief model and supported by motivational interview
Description: In the three-month study, primigravida women in the initiative group will be given a web-based childbirth preparation program, which is prepared based on the Health Belief Model and supported by motivational interviews. Before starting the training program, pre-test will be applied to pregnant women and a five-week program will be implemented. A final test will be applied at the end of the program. The birth process will be evaluated immediately after the pregnant women give birth.
Study NCT06700538 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARO-INHBE
Description: SC injection
Study NCT05084690 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unilateral resistance training
Description: Unilateral resistance training of the elbow flexors
Study NCT06700538 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: calculated volume to match active treatment by SC injection
Study NCT06700538 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: SC injection
Study NCT06700538 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tirzepatide
Description: SC injection